FDAnews
www.fdanews.com/articles/149975-celgene-says-fda-panel-won-rsquo-t-review-pomalidomide

Celgene Says FDA Panel Won’t Review Pomalidomide

October 4, 2012
Celgene said that a Food and Drug Administration panel will not review its multiple myeloma drug pomalidomide in November.
Businessweek